Search

Yu Feng Jiang

from Hackensack, NJ
Age ~63

Yu Jiang Phones & Addresses

  • Hackensack, NJ
  • Brooklyn, NY
  • 64 Broadway, Manhattan, NY 10002 (212) 925-8396
  • 131 Henry St, New York, NY 10002 (212) 227-4283
  • Little Egg Harbor Twp, NJ
  • Depew, NY

Work

Company: New york university Sep 2009 Position: Research assistant

Education

School / High School: Polytechnic School of Engineering of New York University- Brooklyn, NY 2009 Specialities: PhD in Control and Optimization

Skills

MATLAB/Simulink • Mathematical Modeling • Algorithm Development • Optimization • Control Systems Design

Professional Records

License Records

Yu Jiang

License #:
28864 - Active
Issued Date:
Dec 20, 2010
Renew Date:
Dec 1, 2015
Expiration Date:
Nov 30, 2017
Type:
Certified Public Accountant

Yu Jiang

Address:
Brooklyn, NY 11206
License #:
CO253144 - Expired
Category:
Cosmetology
Type:
Cosmetologist

Resumes

Resumes

Yu Jiang Photo 1

Senior Food Technologist And Sqf Practitioner

View page
Location:
2720 Vanderbilt Ave, North Carolina
Industry:
Food Production
Work:
Wonton Food Inc
Senior Food Technologist and Sqf Practitioner

North Carolina State University Feb 2011 - Mar 2011
Interpreter and Assistant

Ieh Laboratories and Consulting Group May 2010 - Jul 2010
Quality Control Laboratory Analyst

First Hospital Jul 2009 - Aug 2009
Nutrition Department of
Education:
North Carolina State University 2008 - 2011
Master of Science, Masters, Nutrition, Food Science
Zhejiang University (Zju) 2005 - 2008
Bachelors, Bachelor of Science, Biotechnology
Skills:
Food Science
Gmp
Haccp
Quality System
Microbiology
Food
Sensory Evaluation
Food Technology
Quality Control
Food Safety
Iso 22000
Dairy
Laboratory
Iso 17025
Food Microbiology
Nutrition
Pcr
Interests:
Science and Technology
Environment
Languages:
English
Certifications:
Implementing Sqf Systems(Post-Farm Gate)
Advanced Haccp
Sqf Institute, License A0002642
International Haccp Alliance: Heb University
License A0002642
Yu Jiang Photo 2

President

View page
Location:
Brooklyn, NY
Industry:
Education Management
Work:
Iece Usa
President
Skills:
International Education
International Business
Cultural Competency
Program Management
Intercultural Communication
International Relations
International Marketing
Translation
International Development
Chinese
Program Evaluation
Mandarin
Languages:
Mandarin
English
Yu Jiang Photo 3

Yu Jiang

View page
Yu Jiang Photo 4

Yu Jiang

View page
Industry:
Education Management
Yu Jiang Photo 5

Yu Jiang

View page
Skills:
Leadership
Microsoft Office
Microsoft Word
Powerpoint
Research
Microsoft Excel
Social Media
Marketing
Public Speaking
Customer Service
Yu Jiang Photo 6

Yu Jiang

View page
Yu Jiang Photo 7

Yu Jiang

View page
Yu Jiang Photo 8

Process Development Engineer At Lam Research

View page
Position:
Process Development Engineer at Lam Research
Location:
San Jose, California
Industry:
Semiconductors
Work:
Lam Research since Jun 2012
Process Development Engineer

Novellus Systems Jun 2011 - Jun 2012
Process Development Engineer

Lawrence Berkeley National Laboratory Nov 2009 - Jun 2011
Chemist Postdoc Fellow

University of California, Santa Cruz Sep 2004 - Aug 2009
Graduate Student Researcher

Novellus Systems Jun 2008 - Sep 2008
Process Intern
Education:
University of California, Santa Cruz 2004 - 2009
Ph.D, Condensed Matter Physics
University of Science and Technology of China 1999 - 2004
B.S., Physics
Skills:
Fortran
Spectroscopy
Solid State Physics
X-ray
English
Mandarin
Linux
Shell Scripting
Chinese
LaTeX
Thin Films
Materials Science
Interests:
new science and technology, reading history books and scientific novels, surfing on the internet, watching films, enjoy good food
Honor & Awards:
Selected Publications “A Study of the local distortions of the Perovskite system La1-xSrxCoO3 (0 ≤ x ≤ 0.35) using the Extended X-ray Absorption Fine Structure technique”, Y. Jiang, F. Bridges, N. Sundaram, D. P. Belanger, I. E. Anderson, J. F. Mitchell, H. Zheng, Phys. Rev. B 80, 144423 (2009). “Local Structure of La1-xSrxCoO3 Determined from EXAFS and Neutron Pair Distribution Function Studies”, N. Sundaram, Y. Jiang, I. E. Anderson, D. P. Belanger, C. H. Booth, F. Bridges, J. F. Mitchell, Th. Proffen, and H. Zheng, Phys. Rev. Lett. 102, 026401 (2009). “Synthesis, Structural, and Optical Properties of Stable ZnS:Cu,Cl Nanocrystals”, C. Corrado, Y. Jiang, F. Oba, M. Kozina, F. Bridges, and J. Z. Zhang, J. Phys. Chem. A. 13, 3830 (2009). “Relationship between macroscopic physical properties and local distortions of low-doping La1-xCaxMnO3: An EXAFS study”, Y. Jiang, F. Bridges, L. Downward, and J. J. Neumeier, Phys. Rev. B 76, 224428 (2007).

Business Records

Name / Title
Company / Classification
Phones & Addresses
Yu Jiang
Director
JIANG'S JADE PALACE INC
136 Bowery STE 203, New York, NY 10013
820 W Spg Crk Pkwy STE 214, Plano, TX 75023
Yu Jiang
Principal
Oyishi Sushi Japanese Food Pla
Eating Place
374 W 46 St, New York, NY 10036
Yu Shu Jiang
WENSHA INTERNATIONAL ENTERPRISE CORP
Cosmetics
88 E Broadway #148, New York, NY 10002
41 Orch St #4A, New York, NY 10002
(212) 625-2035
Yu Ju Jiang
Incorporator
XINGLEI FOOD SERVICE INC
45 Division St SUITE 218, New York, NY 10002
6309 Maccorkle Ave, Charleston, WV 25304
Yu Fang Jiang
CHINA CROWN BUFFET, INC
Yu Jiang
LC CONSULTING GROUP INC
67 Wall St 22, New York, NY 10005
Yu Lan Jiang
EASTERN JIANG BUFFET INC
Yu L. Jiang
President, Director
China Kitchen Jiang's Inc
Eating Place
935 N Beneva Rd, Sarasota, FL 34232
136 Bowery, New York, NY 10013

Publications

Us Patents

Substituted Anilinic Piperidines As Mch Selective Antagonists

View page
US Patent:
6727264, Apr 27, 2004
Filed:
Jul 3, 2002
Appl. No.:
10/188434
Inventors:
Mohammad R. Marzabadi - Ridgewood NJ
John Wetzel - Fairlawn NJ
John E. DeLeon - North Bergen NJ
Yu Jiang - Jersey City NJ
Chien-An Chen - Fresh Meadows NY
Kai Lu - Elmwood Park NJ
Assignee:
Synaptic Pharmaceutical Corporation - Paramus NJ
International Classification:
A61K 31445
US Classification:
514323, 514331, 546200, 546234
Abstract:
This invention is directed to compounds which are selective antagonists for melanin concentrating hormone-1 (MCH1) receptors. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of the compound of the invention and a pharmaceutically acceptable carrier. This invention provides a pharmaceutical composition made by combining a therepeutically effective amount of the compound of this invention and a pharmaceutically acceptable carrier. This invention further provides a process for making a pharmaceutical composition comprising combining a therapeutically effective amount of the compound of the invention and a pharmaceutically acceptable carrier.

Substituted Anilinic Piperidines As Mch Selective Antagonists

View page
US Patent:
7067534, Jun 27, 2006
Filed:
Nov 21, 2003
Appl. No.:
10/719358
Inventors:
Mohammad R. Marzabadi - Ridgewood NJ, US
John Wetzel - Fairlawn NJ, US
John E. DeLeon - North Bergen NJ, US
Yu Jiang - Jersey City NJ, US
Chien-An Chen - Flushing NY, US
Kai Lu - Lake Hiawatha NJ, US
Assignee:
H. Lundbeck A/S - Valby-Copenhagen
International Classification:
A61K 31/445
C07D 401/06
US Classification:
514323, 514331, 546201, 546234
Abstract:
This invention is directed to compounds which are selective antagonists for melanin concentrating hormone-1 (MCH1) receptors. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of the compound of the invention and a pharmaceutically acceptable carrier. This invention provides a pharmaceutical composition made by combining a therapeutically effective amount of the compound of this invention and a pharmaceutically acceptable carrier. This invention further provides a process for making a pharmaceutical composition comprising combining a therapeutically effective amount of the compound of the invention and a pharmaceutically acceptable carrier.

Substituted Alkyl Amido Piperidines

View page
US Patent:
7105544, Sep 12, 2006
Filed:
Jan 14, 2003
Appl. No.:
10/345063
Inventors:
Mohammad R. Marzabadi - Ridgewood NJ, US
John M. Wetzel - Fair Lawn NJ, US
Chien-An Chen - Flushing NY, US
Yu Jiang - Jersey City NJ, US
Kai Lu - Lake Hiawatha NJ, US
Assignee:
Synaptic Pharmaceutical Corporation - Paramus NJ
International Classification:
A61K 31/445
C07D 211/26
US Classification:
514331, 514318, 546200, 546233, 546234
Abstract:
This invention is directed to compounds which are selective antagonists for melanin concentrating hormone-1 (MCH1) receptors. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of the compound of the invention and a pharmaceutically acceptable carrier. This invention provides a pharmaceutical composition made by combining a therapeutically effective amount of the compound of this invention and a pharmaceutically acceptable carrier. This invention further provides a process for making a pharmaceutical composition comprising combining a therapeutically effective amount of the compound of the invention and a pharmaceutically acceptable carrier. This invention also provides a method of reducing the body mass of a subject which comprises administering to the subject an amount of a compound of the invention effective to reduce the body mass of the subject. This invention further provides a method of treating a subject suffering from depression and/or anxiety which comprises administering to the subject an amount of a compound of the invention effective to treat the subject's depression and/or anxiety.

Substituted Alkyl Amido Piperidines

View page
US Patent:
7199135, Apr 3, 2007
Filed:
Jan 6, 2004
Appl. No.:
10/753057
Inventors:
Mohammad R. Marzabadi - Ridgewood NJ, US
John M. Wetzel - Athens OH, US
Chien-An Chen - Fresh Meadows NY, US
Yu Jiang - Jersey City NJ, US
Kai Lu - Elmwood Park NJ, US
Assignee:
H. Lundbeck A/S - Copenhagen-Valby
International Classification:
A61K 31/445
C07D 401/04
US Classification:
514318, 546193, 546194
Abstract:
This invention is directed to compounds which are selective antagonists for melanin concentrating hormone-1 (MCH1) receptors. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of the compound of the invention and a pharmaceutically acceptable carrier. This invention provides a pharmaceutical composition made by combining a therapeutically effective amount of the compound of this invention and a pharmaceutically acceptable carrier. This invention further provides a process for making a pharmaceutical composition comprising combining a therapeutically effective amount of the compound of the invention and a pharmaceutically acceptable carrier. This invention also provides a method of reducing the body mass of a subject which comprises administering to the subject an amount of a compound of the invention effective to reduce the body mass of the subject. This invention further provides a method of treating a subject suffering from depression and/or anxiety which comprises administering to the subject an amount of a compound of the invention effective to treat the subject's depression and/or anxiety.

Arylthiobenzylpiperidine Derivatives

View page
US Patent:
7329656, Feb 12, 2008
Filed:
Sep 21, 2005
Appl. No.:
11/231601
Inventors:
Mohammad R. Marzabadi - Ridgewood NJ, US
Yu Jiang - Jersey City NJ, US
Chien-An Chen - Flushing NY, US
Kai Lu - Lake Hiawatha NJ, US
Kim Andersen - Ridgewood NJ, US
Assignee:
H. Lundbeck A/S - Valby
International Classification:
A61K 31/4545
A61K 31/444
A61K 31/5377
C07D 211/04
C07D 401/04
C07D 413/14
US Classification:
5142315, 514326, 514318, 546193, 546194, 546207, 544124, 544129
Abstract:
This invention is directed to Arylthiobenzylpiperidine derivatives which are ligands at the MCH1 receptor. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention also provides a pharmaceutical composition made by admixing a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention further provides a process for making a pharmaceutical composition comprising combining a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention also provides a method of treating a subject suffering from depression and/or anxiety which comprises administering to the subject a therapeutically effective amount of a compound of the subject invention. This invention also provides a method of treating a subject suffering from obesity which comprises administering to the subject a therapeutically effective amount of a compound of the subject invention.

Spirocyclic Piperidines As Mch1 Antagonists And Uses Thereof

View page
US Patent:
7335665, Feb 26, 2008
Filed:
Jul 3, 2003
Appl. No.:
10/518939
Inventors:
Mohammad R. Marzabadi - Ridgewood NJ, US
Yu Jiang - Jersey City NJ, US
Kai Lu - Lake Hiawatha NJ, US
Chien-An Chen - Flushing NY, US
John E. De Leon - North Bergen NJ, US
John Wetzel - Fairlawn NJ, US
Kim Andersen - Ridgewood NJ, US
Assignee:
H - Lundbeck A/S - Valby
International Classification:
A61K 31/438
C07D 221/20
C07D 491/10
US Classification:
514278, 546 17
Abstract:
This invention is directed to compounds which are selective antagonists for melanin concentrating hormone-1 (MCH1) receptors. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of the compound of the invention and a pharmaceutically acceptable carrier. This invention provides a pharmaceutical composition made by combining a therapeutically effective amount of the compound of this invention and a pharmaceutically acceptable carrier. This invention further provides a process for making a pharmaceutical composition comprising combining a therapeutically effective amount of the compound of the invention and a pharmaceutically acceptable carrier. This invention also provides a method of reducing the body mass of a subject which comprises administering to the subject an amount of a compound of the invention effective to reduce the body mass of the subject. This invention further provides a method of treating a subject suffering from depression and/or anxiety which comprises administering to the subject an amount of a compound of the invention effective to treat the subject=s depression and/or anxiety. This invention further provides a method of treating a subject suffering from a urinary disorder.

Amino Substituted Aryloxybenzylpiperidine Derivatives

View page
US Patent:
7446204, Nov 4, 2008
Filed:
Sep 20, 2005
Appl. No.:
11/230849
Inventors:
Mohammad R. Marzabadi - Ridgewood NJ, US
Chien-An Chen - Flushing NY, US
Yu Jiang - Jersey City NJ, US
Kai Lu - Lake Hiawatha NJ, US
Kim Andersen - Ridgewood NJ, US
Assignee:
H. Lundbeck A/S - Valby - Copenhagen
International Classification:
C07D 211/14
A61K 31/451
US Classification:
546247, 514315
Abstract:
This invention is directed to Amino substituted Aryloxybenzylpiperidine derivatives which are ligands at the MCH1 receptor. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention also provides a pharmaceutical composition made by admixing a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention further provides a process for making a pharmaceutical composition comprising combining a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. This invention also provides a method of treating a subject suffering from depression and/or anxiety which comprises administering to the subject a therapeutically effective amount of a compound of the subject invention. This invention also provides a method of treating a subject suffering from obesity which comprises administering to the subject a therapeutically effective amount of a compound of the subject invention.

Secondary Amino Anilinic Piperidines As Mch1 Antagonists And Uses Thereof

View page
US Patent:
7473698, Jan 6, 2009
Filed:
Jul 3, 2003
Appl. No.:
10/518675
Inventors:
Mohammad R. Marzabadi - Ridgewood NJ, US
Yu Jiang - Jersey City NJ, US
Kai Lu - Lake Hiawatha NJ, US
Chien-An Chen - Flushing NY, US
John E. De Leon - North Bergen NJ, US
John Wetzel - Fairlawn NJ, US
Assignee:
H. Lunbeck A/S - Valby - Copenhagen
International Classification:
A61K 31/4465
US Classification:
514331, 546234
Abstract:
This invention is directed to compounds which are selective antagonists for melanin concentrating hormone-1 (MCH1) receptors. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of the compound of the invention and a pharmaceutically acceptable carrier. This invention provides a pharmaceutical composition made by combining a therapeutically effective amount of the compound of this invention and a pharmaceutically acceptable carrier. This invention further provides a process for making a pharmaceutical composition comprising combining a therapeutically effective amount of the compounds of the invention and a pharmaceutically acceptable carrier. This invention also provides a method of reducing the body mass of a subject which comprises administering to the subject an amount of a compound of the invention effective to reduce the body mass of the subject. This invention further provides a method of treating a subject suffering from depression and/or anxiety which comprises administering to the subject an amount of a compound of the invention effective to treat the subject=s depression and/or anxiety. This invention further provides a method of treating a subject suffering from a urinary disorder.
Yu Feng Jiang from Hackensack, NJ, age ~63 Get Report